Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03066830
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 507
Large-scale testing (Phase 3)Study completedNCT06045221
What this trial is testing

Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 1,698
Testing effectiveness (Phase 2)Study completedNCT00950599
What this trial is testing

Study of Multiple Doses of Saxagliptin (BMS-477118)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 423
Large-scale testing (Phase 3)Study completedNCT00740051
What this trial is testing

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 227
Large-scale testing (Phase 3)Study completedNCT00575588
What this trial is testing

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Who this might be right for
Type 2 Diabetes
AstraZeneca 891
Not applicableStudy completedNCT01857076
What this trial is testing

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

Who this might be right for
ObesityType 2 Diabetes Mellitus
Hospital Sirio-Libanes 75
Large-scale testing (Phase 3)UnknownNCT05226897
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Yooyoung Pharmaceutical Co., Ltd. 256
Not applicableStudy completedNCT02026310
What this trial is testing

Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment

Who this might be right for
Diabetes Mellitus, Type 2
Qifu Li 40
Large-scale testing (Phase 3)Study completedNCT02551874
What this trial is testing

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 650
Post-approval studies (Phase 4)Study completedNCT04531462
What this trial is testing

Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 129
Testing effectiveness (Phase 2)Ended earlyNCT00846391
What this trial is testing

Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 14
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT02831361
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Who this might be right for
Type 2 Diabetes Mellitus
LG Life Sciences 290
Large-scale testing (Phase 3)Study completedNCT04564872
What this trial is testing

HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sichuan Haisco Pharmaceutical Group Co., Ltd 465
Not applicableTemporarily pausedNCT04419779
What this trial is testing

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Fractyl Health Inc. 320
Post-approval studies (Phase 4)Study completedNCT00548808
What this trial is testing

Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 426
Large-scale testing (Phase 3)Study completedNCT00545584
What this trial is testing

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 1,512
Large-scale testing (Phase 3)Study completedNCT00885378
What this trial is testing

Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 166
Large-scale testing (Phase 3)Study completedNCT00622284
What this trial is testing

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,560
Large-scale testing (Phase 3)Study completedNCT01167881
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,549
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation